SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-24-013804
Filing Date
2024-02-14
Accepted
2024-02-14 12:12:40
Documents
16
Period of Report
2024-02-13
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ea193537-8k425_phoenix.htm   iXBRL 8-K 50373
2 AMENDMENT NO. 2 TO THE BUSINESS COMBINATION AGREEMENT, DATED AS OF FEBRUARY 13, ea193537ex2-1_phoenixbio.htm EX-2.1 27555
  Complete submission text file 0001213900-24-013804.txt   319989

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE pbax-20240213.xsd EX-101.SCH 4205
4 XBRL DEFINITION FILE pbax-20240213_def.xml EX-101.DEF 27296
5 XBRL LABEL FILE pbax-20240213_lab.xml EX-101.LAB 37791
6 XBRL PRESENTATION FILE pbax-20240213_pre.xml EX-101.PRE 25916
17 EXTRACTED XBRL INSTANCE DOCUMENT ea193537-8k425_phoenix_htm.xml XML 7306
Mailing Address 2001 MARKET STREET SUITE 3400 PHILADELPHIA PA 19103
Business Address 2001 MARKET STREET SUITE 3400 PHILADELPHIA PA 19103 2157319450
PHOENIX BIOTECH ACQUISITION CORP. (Filer) CIK: 0001870404 (see all company filings)

IRS No.: 871088814 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40877 | Film No.: 24634855
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)